摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Dicyclopropylsulfon | 57899-47-5

中文名称
——
中文别名
——
英文名称
Dicyclopropylsulfon
英文别名
cyclopropyl sulfone;cyclopropylsulfonylcyclopropane
Dicyclopropylsulfon化学式
CAS
57899-47-5
化学式
C6H10O2S
mdl
——
分子量
146.21
InChiKey
OGBZCZYBRFUKKO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.7
  • 重原子数:
    9
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    42.5
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    Dicyclopropylsulfon 生成 β-t-Butoxydicyclopropylsulfon
    参考文献:
    名称:
    .alpha.-Halo sulfones. XVI. .alpha.-Chlorodicyclopropyl sulfone. Its synthesis and behavior toward bases
    摘要:
    DOI:
    10.1021/jo00806a042
  • 作为产物:
    参考文献:
    名称:
    .alpha.-Halo sulfones. XVI. .alpha.-Chlorodicyclopropyl sulfone. Its synthesis and behavior toward bases
    摘要:
    DOI:
    10.1021/jo00806a042
点击查看最新优质反应信息

文献信息

  • [EN] PYRIMIDINE INDOLE DERIVATIVES FOR TREATING CANCER<br/>[FR] DÉRIVÉS DE PYRIMIDINE ET D'INDOLE POUR LE TRAITEMENT DU CANCER
    申请人:ASTRAZENECA AB
    公开号:WO2010073034A1
    公开(公告)日:2010-07-01
    There is provided pyrimidinyl indole compounds of Formula (I), or pharmaceutically acceptable salts thereof, processes for their preparation, pharmaceutical compositions containing them and their use in therapy, particularly for treating cancer.
    提供了式(I)的嘧啶基吲哚化合物,或其药用盐,其制备方法,含有它们的药物组合物以及它们在治疗中的应用,特别是用于治疗癌症。
  • [EN] ANTIVIRAL PYRAZOLOPYRIDINONE COMPOUNDS<br/>[FR] COMPOSÉS ANTIVIRAUX DE PYRAZOLOPYRIDINONE
    申请人:NOVARTIS AG
    公开号:WO2021061898A1
    公开(公告)日:2021-04-01
    The invention provides compounds of Formula (I) as described herein, along with pharmaceutically acceptable salts, pharmaceutical compositions containing such compounds, and methods to use these compounds, salts and compositions for treating viral infections, particularly infections caused by herpesviruses.
    该发明提供了如下所述的化合物的化学式(I),以及药学上可接受的盐、含有这些化合物的药物组合物,以及使用这些化合物、盐和组合物治疗病毒感染的方法,特别是由疱疹病毒引起的感染。
  • ENANTIOSELECTIVE CYCLOPROPENATION OF ALKYNES
    申请人:Zhang X. Peter
    公开号:US20130030170A1
    公开(公告)日:2013-01-31
    The cobalt(II) complex of new D2-symmetric chiral porphyrin 3,5-DiMes-ChenPhyrin, [Co(P2)], has been shown to be a highly effective chiral metalloradical catalyst for enantioselective cyclopropenation of alkynes with acceptor/acceptor-substituted diazo reagents such as α-cyanodiazoacetamides and α-cyanodiazoacetates. The [Co(P2)]-mediated metalloradical cyclopropenation is suitable to a wide range of terminal aromatic and related conjugated alkynes with varied steric and electronic properties, providing the corresponding tri-substituted cyclopropenes in high yields with excellent enantiocontrol of the all-carbon quaternary stereogenic centers. In addition to mild reaction conditions, the Co(II)-based metalloradical catalysis for cyclopropenation features a high degree of functional group tolerance.
    新的D2对称手性卟啉3,5-DiMes-ChenPhyrin的钴(II)络合物[Co(P2)]已被证明是一种高效的手性金属自由基催化剂,用于炔烃与受体/受体取代重氮试剂(如α-氰基重氮乙酰胺和α-氰基重氮乙酸酯)的对映选择性环丙烯化反应。[Co(P2)]介导的金属自由基环丙烯化适用于范围广泛的末端芳香烃和相关共轭炔烃,具有不同的立体和电子性质,可提供相应的三取代环丙烯烃,收率高,对所有碳四取代立体中心的对映选择性控制良好。除了温和的反应条件外,基于Co(II)的金属自由基催化环丙烯化具有高度的官能团容忍性。
  • [EN] CYCLOPROPANATION METHOD<br/>[FR] PROCÉDÉ DE CYCLOPROPANATION
    申请人:OKINAWA INST SCIENCE & TECH SCHOOL CORP
    公开号:WO2019035479A1
    公开(公告)日:2019-02-21
    A cyclopropanation method includes reacting an alcohol, an ester, or an aldehyde with a sulfone in an organic solvent containing a base providing a counter cation to form a cyclopropane; and isolating the cyclopropane. When using the alcohol or ester, the organic solvent further contains a catalyst having an alcohol dehydrogenation activity.
    一种环丙烷化方法包括在含有提供对离子的碱的有机溶剂中,将醇、酯或醛与砜反应以形成环丙烷;并分离出环丙烷。当使用醇或酯时,有机溶剂进一步含有具有醇脱氢活性的催化剂。
  • Novel compounds and compositions as cathepsin S inhibitors
    申请人:——
    公开号:US20030199506A1
    公开(公告)日:2003-10-23
    The present invention relates to novel selective cathepsin S inhibitors, the pharmaceutically acceptable salts and N-oxides thereof, their uses as therapeutic agents and the methods of their making. 1
    本发明涉及新型选择性卡特普西林S抑制剂,其药学上可接受的盐和N-氧化物,以及它们作为治疗剂的用途和制备方法。
查看更多